Joe ,always a first time for everything. We've been in a couple of stocks KERX, TROV and I believe IDRA together.
You never know. Soros just went in on IBB so things may be looking up. It's going to be interesting.
No problem , I always enjoy your posts(except that one ..LOL!).
I agree ,we should breach the 200 day moving average today or tomorrow and could be in for a nice ride up.
Dude, I wasn't talking to YOU. Unless you are clueless Joe.
Get a grip and learn how to use the message board.
...AND I DON'T GIVE A FLIP HOW YOU TRADE OR WHY YOU TRADE OR HOW MUCH YOU MADE OR LOST.
Don't you just love it when shorts fight over useless quotes like a pack of hyenas fighting over a carcass ?
IF we break the 200dma, MAYBE you should POSSIBLY cover your short and
HOPEFULLY avoid getting caught in the upcoming short squeeze.
What's the matter with you people?
You haven't heard of Arkancide before?
HILLARY FOR PRISON 2016!
Seth Klarman's super-secretive and successful hedge fund had its third-losing year ever—here's what happened
Getty / Scott Olson The Baupost Group, the $27 billion Boston-based hedge fund, had its third-losing year ever in its 33-year history in 2015.
Keryx Biopharmaceuticals: Baupost Group's New Position Suggests A Possible Takeout And 100%+ Gains
By Adam Gefvert:In this bullish market, it is good to own at least one stock in your portfolio with takeout potential and a possible 100%+ return. There is a good chance that this could happen with Keryx Biopharmaceuticals (KERX).
Keryx Biopharmaceuticals Could Easily Triple Within the Next Year
Jeremy Richards submits: Keryx Biopharmaceuticals (Nasdaq: KERX) – Should See Double Digit Prices Again
The Case For Keryx Biopharmaceuticals' Analyst Upgrade May Be Justified
By VFC: An analyst upgrade last week and renewed investor interest in Keryx Biopharmaceuticals (KERX) had shares heavily on the move over the past week, a move initially sparked, in part, by positive Phase III da
Why Did Baupost Double Its Stake In Keryx Biopharmaceuticals?
By Matthew Finston:When Baupost makes a buy, investors pay attention.
The Keryx Rebound Is For Real
By VFC: Although relatively modest compared to rebounds in other stocks this week, and with due respect to the possibility that continued market turmoil could derail any rebounding in shares, the Keryx Pharmaceuticals (KERX) rebound to above the three dollar mark is for real, and well justified.
Vulture is in CASH UNTIL MONDAY ...Smart move not gambling on Brexit.
That's why they call him the Birdman of ALKA-SELTZER
double down time for IDRA is here ,folks.
BREXIT has what to do with US Biotech in general???
and IDRA ...in particular?